Immunology & Inflammation Therapeutics
Vera Therapeutics news and milestones
Vera Therapeutics: 8 headlines on record, 4 headlines in the last 90 days.
Data updated Nov 16, 2026 · Back to the company report
8Headlines
4In 90 days
0Milestones
Headlines
Sep 152026
News · Blockonomi
Vera Therapeutics (VERA) stock jumped 4% after two-year ORIGIN3 trial data showed Trutakna slowed kidney decline to normal aging rates in IgAN patients.
Sep 152026
News · YahooFinance
Vera Therapeutics (NASDAQ:VERA) shares rose 13% on Tuesday after the company reported that TRUTAKNA (atacicept-vymj) met all prespecified endpoints in the final efficacy analysis…
Sep 152026
News · markets.businessinsider.com
TRUTAKNA, the first and only FDA-approved BAFF and APRIL inhibitor, met all prespecified endpoints, including unprecedented placebo-adjusted estim...
Sep 52026
News · markets.businessinsider.com
BRISBANE, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 1, 2026, the Comp...
Jul 92026
News · seekingalpha.com
Jul 82026
Press release · The Globe and Mail
Detailed price information for Vera Therapeutics Inc Cl A (VERA-Q) from The Globe and Mail including charting and trades.
Nov 16, 20252025
News · jdsupra.com
Oct 28, 20242024
Sources: the outlets named on each headline, each story once
How to cite
Vera Therapeutics, News. Alion, Nov 16, 2026. https://alion.io/company/veratx/news
